ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.04.03.535346

Publication URI: http://dx.doi.org/10.1101/2023.04.03.535346

Type: Preprint